Simulations Plus, Inc. (NASDAQ:SLP) Sees Significant Growth in Short Interest

Simulations Plus, Inc. (NASDAQ:SLP) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 330,100 shares, an increase of 27.6% from the June 30th total of 258,800 shares. Based on an average daily trading volume, of 134,800 shares, the short-interest ratio is currently 2.4 days. Approximately 2.7% of the company’s stock are sold short.

In other news, Director John Kenneth Paglia sold 690 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $37.86, for a total value of $26,123.40. Following the completion of the sale, the director now owns 2,112 shares in the company, valued at approximately $79,960.32. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Walter S. Woltosz sold 18,500 shares of the company’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $25.67, for a total transaction of $474,895.00. Following the completion of the sale, the director now owns 5,178,083 shares of the company’s stock, valued at approximately $132,921,390.61. The disclosure for this sale can be found here. Corporate insiders own 31.57% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Advisor Group Inc. boosted its holdings in Simulations Plus by 156.9% in the fourth quarter. Advisor Group Inc. now owns 2,112 shares of the technology company’s stock valued at $42,000 after acquiring an additional 1,290 shares in the last quarter. BNP Paribas Arbitrage SA boosted its holdings in Simulations Plus by 59,875.0% in the first quarter. BNP Paribas Arbitrage SA now owns 2,399 shares of the technology company’s stock valued at $51,000 after acquiring an additional 2,395 shares in the last quarter. Metropolitan Life Insurance Co. NY bought a new stake in Simulations Plus in the fourth quarter valued at $79,000. Oppenheimer Asset Management Inc. boosted its holdings in Simulations Plus by 5.9% in the second quarter. Oppenheimer Asset Management Inc. now owns 4,783 shares of the technology company’s stock valued at $137,000 after acquiring an additional 265 shares in the last quarter. Finally, MetLife Investment Advisors LLC bought a new stake in Simulations Plus in the fourth quarter valued at $108,000. Hedge funds and other institutional investors own 41.26% of the company’s stock.

Several equities analysts recently weighed in on SLP shares. Zacks Investment Research upgraded shares of Simulations Plus from a “hold” rating to a “strong-buy” rating and set a $37.00 price target for the company in a research report on Friday, July 19th. BidaskClub upgraded shares of Simulations Plus from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 15th. Finally, ValuEngine lowered shares of Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 2nd.

SLP traded down $0.38 on Monday, reaching $37.66. The company had a trading volume of 170,224 shares, compared to its average volume of 86,471. The business has a 50 day moving average of $33.63. The stock has a market capitalization of $696.70 million, a P/E ratio of 75.32 and a beta of -0.35. Simulations Plus has a 52-week low of $17.18 and a 52-week high of $41.95.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, July 10th. The technology company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. The business had revenue of $9.94 million for the quarter, compared to the consensus estimate of $9.85 million. Simulations Plus had a net margin of 24.09% and a return on equity of 23.48%. Equities research analysts anticipate that Simulations Plus will post 0.46 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Thursday, July 25th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend was Wednesday, July 24th. Simulations Plus’s dividend payout ratio is 48.00%.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Recommended Story: How mutual funds make money

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit